Advertisement

Table of Contents

November 13, 2018; 2 (21)

POINT-COUNTERPOINT

EXCEPTIONAL CASE REPORTS

STIMULUS REPORT

REVIEW ARTICLES

HEMATOPOIESIS AND STEM CELLS

IMMUNOBIOLOGY AND IMMUNOTHERAPY

LYMPHOID NEOPLASIA

MYELOID NEOPLASIA

  • Impact of somatic and germline mutations on the outcome of systemic mastocytosis
    Impact of somatic and germline mutations on the outcome of systemic mastocytosis
    Javier I. Muñoz-González, María Jara-Acevedo, Iván Alvarez-Twose, Jason D. Merker, Cristina Teodosio, Yanli Hou, Ana Henriques, Krishna M. Roskin, Laura Sanchez-Muñoz, Albert G. Tsai, Carolina Caldas, Almudena Matito, J. Ignacio Sánchez-Gallego, Andrea Mayado, Noelia Dasilva-Freire, Jason R. Gotlib, Luis Escribano, Alberto Orfao and Andrés C. García-Montero
  • Recurrent <em>CCND3</em> mutations in <em>MLL</em>-rearranged acute myeloid leukemia
    Recurrent CCND3 mutations in MLL-rearranged acute myeloid leukemia
    Hidemasa Matsuo, Kenichi Yoshida, Kazutaka Fukumura, Kana Nakatani, Yuki Noguchi, Saho Takasaki, Mina Noura, Yusuke Shiozawa, Yuichi Shiraishi, Kenichi Chiba, Hiroko Tanaka, Ai Okada, Yasuhito Nannya, June Takeda, Hiroo Ueno, Norio Shiba, Genki Yamato, Hiroshi Handa, Yuichiro Ono, Nobuhiro Hiramoto, Takayuki Ishikawa, Kensuke Usuki, Ken Ishiyama, Shuichi Miyawaki, Hidehiro Itonaga, Yasushi Miyazaki, Machiko Kawamura, Hiroki Yamaguchi, Nobutaka Kiyokawa, Daisuke Tomizawa, Takashi Taga, Akio Tawa, Yasuhide Hayashi, Hiroyuki Mano, Satoru Miyano, Yasuhiko Kamikubo, Seishi Ogawa and Souichi Adachi
  • Aberrant GSK3β nuclear localization promotes AML growth and drug resistance
    Aberrant GSK3β nuclear localization promotes AML growth and drug resistance
    James J. Ignatz-Hoover, Victoria Wang, Nathan M. Mackowski, Anne J. Roe, Isaac K. Ghansah, Masumi Ueda, Hillard M. Lazarus, Marcos de Lima, Elisabeth Paietta, Hugo Fernandez, Larry Cripe, Martin Tallman and David N. Wald
  • Mayo alliance prognostic system for mastocytosis: clinical and hybrid clinical-molecular models
    Mayo alliance prognostic system for mastocytosis: clinical and hybrid clinical-molecular models
    Animesh Pardanani, Sahrish Shah, Francesco Mannelli, Yoseph C. Elala, Paola Guglielmelli, Terra L. Lasho, Mrinal M. Patnaik, Naseema Gangat, Rhett P. Ketterling, Kaaren K. Reichard, Curtis A. Hanson, Alessandro M. Vannucchi and Ayalew Tefferi

PLATELETS AND THROMBOPOIESIS

RED CELLS, IRON, AND ERYTHROPOIESIS

THROMBOSIS AND HEMOSTASIS

TRANSFUSION MEDICINE

TRANSPLANTATION

  • Myeloablative vs reduced-intensity conditioning allogeneic hematopoietic cell transplantation for chronic myeloid leukemia
    Myeloablative vs reduced-intensity conditioning allogeneic hematopoietic cell transplantation for chronic myeloid leukemia
    Saurabh Chhabra, Kwang Woo Ahn, Zhen-Huan Hu, Sandeep Jain, Amer Assal, Jan Cerny, Edward A. Copelan, Andrew Daly, Zachariah DeFilipp, Shahinaz M. Gadalla, Robert Peter Gale, Siddhartha Ganguly, Betty K. Hamilton, Gerhard Carl Hildebrandt, Jack W. Hsu, Yoshihiro Inamoto, Abraham S. Kanate, H. Jean Khoury, Hillard M. Lazarus, Mark R. Litzow, Sunita Nathan, Richard F. Olsson, Attaphol Pawarode, Olle Ringden, Jacob M. Rowe, Ayman Saad, Bipin N. Savani, Harry C. Schouten, Sachiko Seo, Nirav N. Shah, Melhem Solh, Robert K. Stuart, Celalettin Ustun, Ann E. Woolfrey, Jean A. Yared, Edwin P. Alyea, Matt E. Kalaycio, Uday Popat, Ronald M. Sobecks and Wael Saber

GLOBAL ADVANCES